Product Information
VERAPAMIL SR 180 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.0471 per EA under NDC 00591288201. Its NADAC has been published 662 times since Nov 28, 2013.
FDA first approved this application on May 29, 1990. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
180 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00591288201
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA019614FDA Approved
5/29/1990
TE Code
AB
On Market Since
5/29/1990
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL SR 180 MG CAPSULE has been published 662 times since Nov 28, 2013, and over the history we have for it it has risen 83.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0471 per EA |
|---|---|
| All-time high | $2.2961 (Mar 11, 2026) |
| All-time low | $0.4773 (Feb 18, 2015) |
| 52-week high | $2.2961 |
| 52-week low | $1.0263 |
| Median price | $1.1579 |
| Average price | $1.1241 |
| Largest weekly change | +45.5% (Mar 18, 2015) |
| Weeks tracked | 662 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
0.0%
3M
-16.6%
6M
-54.4%
1Y
+2.0%
3Y
-15.9%
5Y
-14.4%
All
+83.2%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VERAPAMIL SR 180 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL SR 180 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $1.0471 per EA (NDC 00591288201), effective Jul 29, 2026.
How has the price of VERAPAMIL SR 180 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VERAPAMIL SR 180 MG CAPSULE has risen 83.2%. It has been tracked across 662 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VERAPAMIL SR 180 MG CAPSULE?
Since Nov 28, 2013, the NADAC for VERAPAMIL SR 180 MG CAPSULE has ranged from a low of $0.4773 (Feb 18, 2015) to a high of $2.2961 (Mar 11, 2026), with a median of $1.1579 per EA.
Are there cheaper alternatives to VERAPAMIL SR 180 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VERAPAMIL SR 180 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures VERAPAMIL SR 180 MG CAPSULE?
VERAPAMIL SR 180 MG CAPSULE (NDC 00591288201) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.